Adtalem Global Education Unveils Upcoming Earnings Conference
Adtalem Global Education Announces Conference Call
Adtalem Global Education Inc. (NYSE: ATGE), the foremost healthcare educator in the U.S., has officially announced its second quarter fiscal year 2025 results will be released following the market's closure on a Thursday. The company invites all stakeholders to join a subsequent conference call to discuss these results.
Details of the Earnings Call
The conference call is scheduled for 4:00 p.m. CT (5:00 p.m. ET). Participants can join by dialing +1 877-407-6184 if they are in the U.S. or for international attendees, the number is +1 201-389-0877. When prompted, participants should state "Adtalem earnings call" or provide the conference ID: 13750710.
How to Access the Simulcast
In addition to the call, Adtalem will simulcast the event via its investor relations website, providing another avenue for stakeholders to engage with the company’s fiscal discussions.
Replay of the Call
For those unable to participate live, Adtalem plans to archive a replay of the call for a period of 30 days. To access this replay, dial +1 877-660-6853 within the U.S. or +1 201-612-7415 for international participation. The same conference ID of 13750710 will apply.
About Adtalem Global Education
Adtalem Global Education stands as a beacon of healthcare education in the United States, committed to shaping the future by fostering a diverse workforce. Through high-quality academic programs, the company aligns education pathways with industry demands, ultimately empowering individuals to achieve their fullest potential.
Our Commitment to Excellence
The dedication to excellence and inclusivity is evident through Adtalem's vast network, which caters to over 90,000 current students. This expansive presence is backed by a supportive community of approximately 350,000 alumni and nearly 10,000 employees who are dedicated to transforming the educational landscape.
Connect with Us
For more information, visit Adtalem.com and connect on popular social media platforms such as LinkedIn, Instagram, and Facebook. Adtalem’s commitment to healthcare education is highlighted through its involvement and outreach in various educational initiatives.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call serves to discuss the financial results of Adtalem Global Education for the second quarter fiscal year 2025.
How can I participate in the call?
To participate, dial +1 877-407-6184 for U.S. participants or +1 201-389-0877 for international calls and provide the conference ID.
Where can I access the replay of the call?
The replay can be accessed by calling +1 877-660-6853 for U.S. listeners or +1 201-612-7415 for international calls using the same conference ID.
What does Adtalem Global Education focus on?
Adtalem focuses on providing quality healthcare education and preparing a diverse workforce through innovative academic programs.
How many students does Adtalem serve?
Adtalem serves over 90,000 current students across its network of institutions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.